Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Specific Questionnaire to Assess the Tolerability of the Different Therapeutic Strategies in Rheumatoid Arthritis

NCT02401620 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT02401620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02401620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Specific Questionnaire to Assess the Tolerability of the Different Therapeutic Strategies in Rheumatoid Arthritis
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2014
Completion date
December 31, 2015
Enrollment
66 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis